Cargando…

Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice

SARS-CoV (severe acute respiratory syndrome-associated coronavirus) strain GZ50 was partially purified and inactivated with 1:2000 formaldehyde. In cell culture the inactivated virus blocked the replication of live virus by decreasing the TCID(5.0) of the live virus 10(3.6) to 10(4.6) times. Inactiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qu, Di, Zheng, Bojian, Yao, Xin, Guan, Yi, Yuan, Zheng-Hong, Zhong, Nan-Shan, Lu, Li-Wei, Xie, Jian-Ping, Wen, Yu-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115388/ https://www.ncbi.nlm.nih.gov/pubmed/15603894 http://dx.doi.org/10.1016/j.vaccine.2004.07.031

Ejemplares similares

Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS‐CoV‐2
por: Hu, Xiumei, et al.
Publicado: (2020)

Intranasal Protollin Formulated Recombinant SARS-CoV S Protein Elicits Respiratory and Serum Neutralizing Antibodies
por: Barnard, Dale, et al.
Publicado: (2007)

Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization
por: Zhang, Yuan, et al.
Publicado: (2007)

Stability and inactivation of SARS coronavirus
por: Rabenau, H. F., et al.
Publicado: (2004)

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Immune responses and histopathological changes in rabbits immunized with inactivated SARS coronavirus
por: Zhang, Chuan-hai, et al.
Publicado: (2008)

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
por: Yao, Zhixian, et al.
Publicado: (2020)

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants
por: Moser, Michael J., et al.
Publicado: (2023)

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
por: Darnell, Miriam E.R., et al.
Publicado: (2004)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
por: Halwe, Sandro, et al.
Publicado: (2021)

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
por: Liang, Huang, et al.
Publicado: (2022)

Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
por: Hu, Mary C., et al.
Publicado: (2007)

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
por: Zeng, Lei-Ping, et al.
Publicado: (2017)

Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice
por: Liu, Mei-Qin, et al.
Publicado: (2022)

Reducing transmission of SARS-CoV-2 with intranasal prophylaxis
por: Boiardi, Federico, et al.
Publicado: (2020)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

An intranasal ASO therapeutic targeting SARS-CoV-2
por: Zhu, Chi, et al.
Publicado: (2022)

Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice
por: Li, Jia-Qi, et al.
Publicado: (2021)

Is serum in childhood naturally protective against SARS-coronavirus?
por: Li, Qian, et al.
Publicado: (2004)

Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days
por: Xu, Qiu-Yan, et al.
Publicado: (2021)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Prediction of quaternary assembly of SARS coronavirus peplomer
por: Bernini, Andrea, et al.
Publicado: (2004)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
por: Wang, Jing, et al.
Publicado: (2023)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Evaluating SARS-CoV-2 antibody reactivity to natural exposure and inactivated vaccination with peptide microarrays
por: Zheng, Peiyan, et al.
Publicado: (2023)

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
por: Zhang, Hui, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination induces an intranasal mucosal response characterized by neutralizing antibodies
por: Cao, Kevin T., et al.
Publicado: (2023)

Intravenous, Intratracheal, and Intranasal Inoculation of Swine with SARS-CoV-2
por: Buckley, Alexandra, et al.
Publicado: (2021)

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine
por: Ju, Bin, et al.
Publicado: (2022)

Antibodies to SARS Coronavirus in Civets
por: Tu, Changchun, et al.
Publicado: (2004)

Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
por: Huang, Min, et al.
Publicado: (2020)

Impact of heat-inactivation on the detection of SARS-CoV-2 IgM and IgG antibody by ELISA
por: Hu, Xiumei, et al.
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
por: Sengupta, Anirban, et al.
Publicado: (2022)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

Intranasal gene therapy to prevent infection by SARS-CoV-2 variants
por: Sims, Joshua J., et al.
Publicado: (2021)

Coronaviruses and SARS-COV-2
por: HASÖKSÜZ, Mustafa, et al.
Publicado: (2020)

Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
por: Lin, Qingqing, et al.
Publicado: (2020)

SARS-CoV-2 is an appropriate name for the new coronavirus
por: Wu, Yuntao, et al.
Publicado: (2020)

Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
por: Chou, Te-hui W., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_tul18s21ivombetcbmqvrl4jdp